Sosei enters distribution pact with ASKA Pharma for emergency contraceptive pill NorLevo
Sosei Group Corporation, the biopharmaceutical company, announced that Sosei Co, Ltd, its wholly-owned Japanese subsidiary, has entered into a definitive distribution agreement with ASKA Pharmaceuticals Co., Ltd for the commercialisation of the emergency contraceptive pill SOH-075 (NorLevo).
NorLevo is an oral emergency contraceptive 'morning after pill' which is used to prevent unwanted pregnancy after unprotected intercourse. NorLevo contains only levonorgestrel as an active ingredient. The dosing is started within 72 hours after unprotected sexual intercourse. NorLevo was first launched in Europe in 1999 and is currently approved in some 60 countries, the product being both safe and effective as an oral emergency contraceptive for post-coital use.
Comments